Showing results (2321-2330 of 2,942) with videos related to
Sort By:
Pageof 295
Immunology Letters|December 23, 2003
Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytesKevin T Hogan, Michael A Coppola, Christine L Gatlin, et al.Schizophrenia Bulletin|December 28, 2020
A Role for Somatostatin-Positive Interneurons in Neuro-Oscillatory and Information Processing Deficits in SchizophreniaAlice B Van Derveer, Georgia Bastos, Antanovia D Ferrell, et al.Women'S Health (London, England)|June 10, 2022
The psychological impact of the COVID-19 pandemic and a SARS-CoV-2 testing programme on obstetric patients and healthcare workersAbigail M Ross, Serine Ramlawi, Romina Fakhraei, et al.The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the ratJ B Owolabi, G Rizkalla, A Tehim, et al.Human Molecular Genetics|September 1, 1996
The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor geneS K Sidhar, J Clark, S Gill, et al.Human Molecular Genetics|March 1, 1996
Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophyC H Wang, J Xu, T A Carter, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Construction of a yeast artificial chromosome contig spanning the spinal muscular atrophy disease gene regionP W Kleyn, C H Wang, L L Lien, et al.Journal of the American College of Cardiology|February 1, 1995
Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II)B J Gersh, J H Chesebro, E Braunwald, et al.British Journal of Haematology|April 26, 2002
Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosisChristine J Harrison, Helen Mazzullo, Fiona M Ross, et al.Epidemics|December 11, 2017
Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programsJennifer M Ross, Roger Ying, Connie L Celum, et al.Pageof 295